Synthesis and evaluation of haloperidol ester prodrugs metabolically activated by human carboxylesterase
暂无分享,去创建一个
M. Hosokawa | Masato Takahashi | M. Haba | Tomoki Uehara | Minori Nonaka | Yuka Minagawa | Riona Yamazaki
[1] Y. Choi,et al. Microsuspension of fatty acid esters of entecavir for parenteral sustained delivery , 2018, International journal of pharmaceutics.
[2] M. Hosokawa,et al. Chemical synthesis of an indomethacin ester prodrug and its metabolic activation by human carboxylesterase 1. , 2018, Bioorganic & medicinal chemistry letters.
[3] W. Cui,et al. Electrospun fibrous membranes featuring sustained release of ibuprofen reduce adhesion and improve neurological function following lumbar laminectomy , 2017, Journal of controlled release : official journal of the Controlled Release Society.
[4] Benjamin J. Whalley,et al. A novel PEG–haloperidol conjugate with a non-degradable linker shows the feasibility of using polymer–drug conjugates in a non-prodrug fashion , 2016 .
[5] F. Drago,et al. Antiangiogenic Effect of (±)-Haloperidol Metabolite II Valproate Ester [(±)-MRJF22] in Human Microvascular Retinal Endothelial Cells. , 2016, Journal of medicinal chemistry.
[6] J. Leysen,et al. Lipophilic nalmefene prodrugs to achieve a one-month sustained release. , 2016, Journal of controlled release : official journal of the Controlled Release Society.
[7] M. Hosokawa,et al. Synthesis and evaluation of atorvastatin esters as prodrugs metabolically activated by human carboxylesterases. , 2016, Bioorganic & medicinal chemistry letters.
[8] A. Cataldi,et al. Haloperidol metabolite II prodrug: asymmetric synthesis and biological evaluation on rat C6 glioma cells. , 2015, European journal of medicinal chemistry.
[9] K. Brain,et al. Skin permeation and ex vivo skin metabolism of O-acyl haloperidol ester prodrugs. , 2009, International journal of pharmaceutics.
[10] K. Brain,et al. Synthesis of haloperidol prodrugs and their hydrolysis by porcine liver esterase. , 2008, Drug metabolism letters.
[11] Masakiyo Hosokawa,et al. Structure and Catalytic Properties of Carboxylesterase Isozymes Involved in Metabolic Activation of Prodrugs , 2008, Molecules.
[12] K. Chiba,et al. Genomic Structure and Transcriptional Regulation of the Rat, Mouse, and Human Carboxylesterase Genes , 2007, Drug metabolism reviews.
[13] F. Akhlaghi,et al. Anti-Influenza Prodrug Oseltamivir Is Activated by Carboxylesterase Human Carboxylesterase 1, and the Activation Is Inhibited by Antiplatelet Agent Clopidogrel , 2006, Journal of Pharmacology and Experimental Therapeutics.
[14] Teruko Imai,et al. Substrate Specificity of Carboxylesterase Isozymes and Their Contribution to Hydrolase Activity in Human Liver and Small Intestine , 2006, Drug Metabolism and Disposition.
[15] Tetsuo Satoh,et al. Structure, function and regulation of carboxylesterases. , 2006, Chemico-biological interactions.
[16] D. Murry,et al. Methylphenidate Is Stereoselectively Hydrolyzed by Human Carboxylesterase CES1A1 , 2004, Journal of Pharmacology and Experimental Therapeutics.
[17] P. Kuhn,et al. Crystal structure of human carboxylesterase 1 complexed with the Alzheimer's drug tacrine: from binding promiscuity to selective inhibition. , 2003, Chemistry & biology.
[18] W. Bosron,et al. Binding and hydrolysis of meperidine by human liver carboxylesterase hCE-1. , 1999, The Journal of pharmacology and experimental therapeutics.
[19] J. Cashman,et al. Human liver carboxylesterase hCE-1: binding specificity for cocaine, heroin, and their metabolites and analogs. , 1997, Drug metabolism and disposition: the biological fate of chemicals.
[20] K Hirano,et al. Hydrolytic profile for ester- or amide-linkage by carboxylesterases pI 5.3 and 4.5 from human liver. , 1997, Biological & pharmaceutical bulletin.
[21] W. Bosron,et al. Metabolism of cocaine and heroin is catalyzed by the same human liver carboxylesterases. , 1996, The Journal of pharmacology and experimental therapeutics.
[22] T. Satoh,et al. Interindividual variation in carboxylesterase levels in human liver microsomes. , 1995, Drug metabolism and disposition: the biological fate of chemicals.
[23] T. Satoh,et al. Metabolic activation of CPT-11, 7-ethyl-10-[4-(1-piperidino)-1- piperidino]carbonyloxycamptothecin, a novel antitumor agent, by carboxylesterase. , 1994, Biological & pharmaceutical bulletin.
[24] M. Jann,et al. Pharmacokinetics of Haloperidol , 1989, Clinical pharmacokinetics.
[25] K. Nambu,et al. Enzymatic hydrolysis of haloperidol decanoate and its inhibition by proteins. , 1987, Biochemical pharmacology.
[26] T. Fukami,et al. The emerging role of human esterases. , 2012, Drug metabolism and pharmacokinetics.
[27] R. Beresford,et al. Haloperidol Decanoate , 2012, Drugs.
[28] M Hosokawa,et al. The mammalian carboxylesterases: from molecules to functions. , 1998, Annual review of pharmacology and toxicology.